{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:23:46Z","timestamp":1791559426154,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.chest.2020.09.238","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:10:26Z","timestamp":1600935026000},"page":"1197-1207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C"],"prefix":"10.1016","volume":"159","author":[{"given":"Marie-Caroline","family":"Certain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Camille","family":"Chaumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Seferian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Favrolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Boissin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Traclet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Rosa","family":"Ghigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bonniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2020.09.238_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.238_bib2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"04","key":"10.1016\/j.chest.2020.09.238_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0029-1233310","article-title":"Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences","volume":"30","author":"Montani","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.09.238_bib4","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2020.09.238_bib5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.chest.2020.09.238_bib6","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1183\/13993003.00026-2016","article-title":"Pulmonary veno-occlusive disease","volume":"47","author":"Montani","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2020.09.238_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.09.238_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng.2844","article-title":"EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension","volume":"46","author":"Eyries","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.chest.2020.09.238_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.00814-2015","article-title":"Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease","volume":"46","author":"Montani","year":"2015","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2020.09.238_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","article-title":"Chemotherapy-induced pulmonary hypertension: role of alkylating agents","volume":"185","author":"Ranchoux","year":"2015","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.chest.2020.09.238_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thx.40.11.874","article-title":"Pulmonary veno-occlusive disease after chemotherapy","volume":"40","author":"Knight","year":"1985","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2020.09.238_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1513\/AnnalsATS.201312-426LE","article-title":"Recovery from mitomycin-induced pulmonary arterial hypertension","volume":"11","author":"Botros","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2020.09.238_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0169-5002(01)00479-2","article-title":"Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma","volume":"36","author":"Gagnadoux","year":"2002","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.chest.2020.09.238_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s11096-018-0712-y","article-title":"Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension","volume":"40","author":"Chaumais","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"10.1016\/j.chest.2020.09.238_bib15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.lpm.2017.09.026","article-title":"Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease","volume":"46","author":"Savale","year":"2017","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.chest.2020.09.238_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-89-3-352","article-title":"Interstitial pneumonia from mitomycin","volume":"89","author":"Orwoll","year":"1978","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.chest.2020.09.238_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.115.014207","article-title":"Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models","volume":"132","author":"Perros","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chest.2020.09.238_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-2600(16)30438-6","article-title":"Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study","volume":"5","author":"Montani","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.chest.2020.09.238_bib19","unstructured":"Forman D, Bray F, Brewster DH, et\u00a0al, eds.; International Agency for Research on Cancer; World Health Organization; International Association of Cancer Registries. Cancer incidence in five continents Vol. X. IARC Scientific Publications No. 164. 2014. https:\/\/ci5.iarc.fr\/cI5I-x\/old\/vol10\/CI5vol10.pdf. Accessed October 24.\u00a02020."},{"issue":"5","key":"10.1016\/j.chest.2020.09.238_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.respe.2010.06.165","article-title":"Economic burden of anal cancer management in France","volume":"58","author":"Abramowitz","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"5","key":"10.1016\/j.chest.2020.09.238_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.healun.2017.09.022","article-title":"Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease","volume":"37","author":"Nossent","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"24","key":"10.1016\/j.chest.2020.09.238_bib22","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1016\/0006-2952(88)90348-6","article-title":"Effect of mitomycin C on prostacyclin synthesis by human endothelial cells","volume":"37","author":"Duperray","year":"1988","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.chest.2020.09.238_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/taap.1995.1012","article-title":"Toxicity of mitomycin C toward cultured pulmonary artery endothelium","volume":"130","author":"Hoorn","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"10.1016\/j.chest.2020.09.238_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"40","author":"Glynne-Jones","year":"2014","journal-title":"Eur J Surg Oncol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220347383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220347383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:32:13Z","timestamp":1757925133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220347383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0012369220347383"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.09.238","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.09.238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}